US NUCLEAR'S PARTNER MIFTEC, ACHIEVES CRITICAL MILESTONES FOR BOTH
COMPANIES TO BECOME MAJOR SUPPLIERS IN $10B RADIOISOTOPE
MARKET
Atlantic, GA. -- March 26th, 2019 -- InvestorsHub
NewsWire -- Emerging Microcaps -- US Nuclear Corp., (USOTC:
UCLE)
-
Last year, US
Nuclear and MIFTEC announced a revolutionary and patented new way
to make radioisotopes from fusion energy at half today's cost and
formed an exclusive partnership to join forces and become major
radioisotope suppliers.
-
Since then,
US Nuclear's
exclusive
partner, MIFTEC, has decisively proven at UNR TeraWatt
Facility that
their radical new fusion technology works exactly as predicted and
can make billions of dollars of high-quality radioisotopes for half
the current cost of fission reactors and has numerous other big
advantages.
-
MIFTEC hired a
leading nuclear fusion design engineer from a National Lab and has
already completed design plans for the first commercial 10MA LTD-X
(linear transformer driver) Staged Z-Pinch Fusion Generator that
can be built in between 1 and 2 years, and US Nuclear is now
looking for locations to build MIFTEC's Fusion
Generators.
-
Suffering from
severe shortages, the medical radioisotope market is $10B annually
and could be at least double if the supply was bigger, more
reliable, and if the cost was lower.
-
Radioisotopes
made from fusion power are about half the cost of radioisotopes
currently made by fission reactors.
-
US
Nuclear and MIFTEC are the only companies in the world that
are able
to use MIFTEC's
breakthrough fusion power to make abundant high-quality
radioisotopes
at half the cost. The closest competitor has only been able to
generate 1/100,000th
the power that
MIFTEC has already demonstrated.
Medical
radioisotopes are desperately needed because they are the
best-known tools for diagnosing cancer and heart disease and for
treating about half of all cancers. Currently, radioisotopes are
largely made in only 5 large nuclear fission reactors that are very
costly, hazardous, subject to unexpected shutdowns, produce
dangerous long-term nuclear waste, and are all outside of the
United States. Worldwide
shortages are already impacting the quality of healthcare globally
and
experts warn about the likelihood
of further deterioration until a major new source for supply comes
on line. Last year, the Chalk River fission reactor in Canada that
was one of the largest suppliers of radioisotopes, shut down
permanently and is now being demolished.
In response to
the critical and growing shortage of radioisotopes, the industry is
moving toward smaller fission nuclear reactors that use LEU instead
of HEU, however the high cost of handling the hazardous nuclear
waste is causing concerns about rising costs that may not be
competitive with radioisotopes from the larger current HEU driven
fission reactors. However, since supply is the highest priority,
the higher prices will just have to be temporarily tolerated until
a new solution turns up.
US Nuclear
and MIFTEC Have Proven a Better, Safer and Much Cheaper
Way
Last year, US Nuclear (OTC:
UCLE) shares ran from $.40 to $5.00 when the company announced
that their partner, MIFTEC Labs discovered and patented a
revolutionary new way to make abundant high-quality
radioisotopes. Since then, the companies have been quietly moving
forward and sharing very little news while US Nuclear shares have
fallen back to around $.50 giving investors a second chance to get
in at bargain share prices.
Recently, Emerging
MicroCaps
interviewed Jerry
Simmons, CEO of MIFTEC Labs and Bob Goldstein, CEO of US Nuclear to
learn more details about their progress and where they stand today.
The interview strongly suggests US Nuclear shares are about to
rocket again, but perhaps higher this time because their milestones
achievements have removed the biggest barriers to successfully
becoming a major player in this unfilled, high-need,
multi-billion-dollar market for essential medical
radioisotopes.
When asked what the biggest
milestone achievements have been since they first announced their
breakthrough technology last year, Jerry Simmons said,
"In the second half of last year we did what nobody else has ever
been able to do. Not even the big government projects. We made
history by generating Neutron Flux in excess of 1010
from fusion power using an isotope of hydrogen from seawater
instead of radioactive enriched uranium. This proves beyond any
doubt that our machine can make the isotopes used in nuclear
medicine (i.e. Mo-99, Tc-99m, cobalt 60, iodine, etc.). It is only
a matter now of simply scaling the power or electric current flow
of our machine up so we can achieve the greater Neutron Flux
of
1012+.
Dr. Hafiz Rahman, President and Chief Scientist and his staff at
MIFTEC Labs and the University of Nevada, Reno National Terawatt
Facility, tells us that our scientific experimental predictions and
the device will work as designed."
The pursuit of fusion power has been
elusive,
and many have heard it for so long, that the common perception is
that fusion power is still a long way off. The truth is that it is
here now and MIFTEC and their sister company Magneto-Internal
Fusion Technologies, Inc.
(MIFTI) have successfully achieved the greatest power ever from
fusion which is the same nuclear energy process happening in our
sun and the stars. The closest competitor known to MIFTEC claims
they have achieved a Neutron Flux of 105
from fusion power. To illustrate how far ahead of the pack MIFTEC
is, consider that they have already achieved 1010
that is
100,000 times more powerful than the closest competitor.
Dr. Hafiz Rahman says,
"To give you an idea of how advanced we are, when we achieve
1015,
it will be 10,000,000,000 (ten billion) times more powerful than
105.
That is more than enough power to create all the Neutron Flux we
need to supply low cost radioisotopes and power for production of
electricity with our compact, low cost machines."
Simmons continuing,
"The machine we used at University of Nevada, Reno National
Terawatt Facility was a 1 MA (1 Mega Amp) machine which limited the
Neutron Flux we could generate to 1010.
Last year, we hired a top nuclear design engineer and he has
already completed the design for our new 10 MA (10 Mega Amps) LTD-X
Staged Z-Pinch Fusion Generator that is designed to generate
1015
Neutron
Flux that is extremely powerful and matches or exceeds the high
power of the fission reactors being used today for radioisotope
production. Our new generators are small and will fit into a
building close to where the radioisotopes will be used. Our
generators will be
only a tiny fraction of the cost of the huge nuclear fission
reactors and linear accelerators, and there will be no long-term
hazardous radioactive waste to contend with that is dangerous and
extremely expensive. Nuclear fission reactors can cost anywhere
from several hundred million dollars to several billion dollars and
we estimate that our machine will sell for around 3 to 5 million
dollars. Our Staged Z-Pinch LTD-X Fusion Generator will be small
and compact and will require very few people to operate. The bottom
line is that we will be able to deliver enormous amounts of
high-quality
radioisotopes
for about half today's cost."
About Bob Goldstein and Jerry Simmons
Bob Goldstein,
the CEO of US Nuclear, graduated from MIT with a degree in
Physics and
has a degree
in Engineering from Stanford. He has authored more than 40
white papers and presentations on radiation measurement and his
work has been met and approved by US Federal standards set by the EPA,
FDA, and NRC. He also works closely with
Los Alamos, Sandia and Jefferson National Labs. His family's first experiences
in
nuclear physics
go back to the 1940's when his
father was involved in the historic Manhattan Project that
developed the atomic bomb.
Mr. Goldstein
founded US Nuclear and is known for delivering the most sensitive,
accurate and reliable instruments in the world. The quality of
their work is confirmed by a list of loyal and repeat customers
such as NASA, the EPA, Department of Energy, U.S. Air Force, U.S.
Army, U.S. Navy, MIT, Pacific Gas & Electric, General Electric,
Lawrence Livermore, Oakridge National Lab and many more.
Jerry Simmons
is the only person in the world who has founded two fusion energy
companies. In 1998, Mr. Simmons co-founded Tri-Alpha Energy that is
a now a multi-billion-dollar company with big early investors such
as Paul Allen's Vulcan Investments and Art Samburg's
hedge fund.
The company is now called TAE Technologies. Jerry also co-founded
Magneto-Internal Fusion Technologies, Inc. (MIFTI) and MIFTEC
Laboratories, Inc. MIFTI has been funded by the DOE/ARPA-E and
private investors. Mr. Simmons is very experienced and well
connected with government officials that are interested in nuclear
fusion based power and radioisotopes that are produced from fusion
power sources. Mr. Simmons has negotiated a work package between
MIFTEC Laboratories and Oak Ridge National Laboratory.
About US Nuclear
US Nuclear has
enjoyed a long-standing financial history of stable sales and
profitability, but in 2017 demand for US Nuclear's
products began
increasing and has continued at a high growth rate since. We saw a
sales increase of 50% in 2017 and 2018 numbers are due out soon and
are expected to show continued strong growth. Several new large
opportunities are blossoming in the underserved radioisotope
market, and the environmental monitoring market that is
forecast to hit $20
billion by 2021. For example, China is converting
all of
their
coal-fired power plants that are responsible for dangerous polluted
air and water, to about 200 fission nuclear reactors that all
require the best radiation monitoring equipment in order to insure
safety. The Chinese nuclear agency claims that each individual
nuclear power plant requires about $8,000,000 in the highest
quality and most reliable radiation monitoring devices and
has already met
with Mr. Goldstein twice last year with the intention of purchasing
large orders of US Nuclear monitoring equipment. With World Nuclear
Power Organization's
forecast for a growing
number of nuclear power plants to produce electricity (none planned
to produce radioisotopes), the demand for radiation monitoring
devices also grows.
Other
large opportunities for US Nuclear are their unique products
recently offered for radon mitigation in homes and offices and the
use of drones to mount their sophisticated monitoring devices.
Radon is commonly found in many homes and is one of the leading
known causes of lung cancer. Goldman Sachs sees the
drone market growing
to a very large size by 2020. Drones are the perfect vehicle for
carrying US Nuclear environmental monitoring devices for public
safety and for national security threats of terrorism that could
impact our air or water.
In
conclusion, US Nuclear is enjoying strong growth from its core
business, and on top of that, is well positioned to become a major
supplier in a multi-billion-dollar healthcare market of
radioisotopes.
Goldstein
says,
"Given the failing state of essential medical isotope production
facilities, this
first-ever achievement to meet and exceed the 1010
milestone
in fusion neutron production could not come at a better time.
Additionally, the projected cost savings of up to 50% over the
current imported resources; the idea of on-site production; the low
cost and shorter time to build the generators, and the
environmental benefit of a non-proliferating process that precludes
the hazards of fission-based methods; should make for important
upgrades ahead in the vital medical isotope supply chain."
US Nuclear reports only 17
million shares outstanding translating to a very small market cap
of about $8 million. Of the 17 million shares outstanding,
management owns about ten million shares. The float is small and
based on a
number of metrics including sales, the
share price is substantially undervalued. Any investor looking at
US Nuclear should run the numbers for themselves and calculate what
the shares could be valued at if their sales mushroomed to the
large numbers that just the radioisotope business can bring. The
big question is, "How much of a $10 Billion-dollar
market (that is
expected to be $17 Billion in 2020), can US Nuclear and MIFTEC own
if they can deliver valuable, high demand radioisotopes at
half-price? And if US Nuclear generates big sales with only 17
million shares outstanding, how high will the price go?
US Nuclear shares appear to
be a bargain and poised for record highs in the not too distant
future.
For more
information:
Emerging MicroCaps - Ph:
303-956-1777
EmergingMicroCaps.com
RACAVALLI@YAHOO.COM